Diaceutics maintains expectations after first quarter
19th May 2020 10:56
(Sharecast News) - Diaceutics said it had made a "good start" to the 2020 financial year on Tuesday, with trading in the first quarter in line with the board's expectations.
Read moreDiaceutics flags serious fall in cancer testing amid Covid-19
29th Apr 2020 09:29
(Sharecast News) - Precision diagnostics commercialisation company Diaceutics announced research results from its Covid-19 oncology tracker on Wednesday, which it said showed the impact of the crisis on cancer testing and diagnosis in the United States.
Read moreDiaceutics beats expectations on revenue and earnings
13th Jan 2020 10:44
(Sharecast News) - Pharmaceutical data analytics and implementation services provider Diaceutics updated the market on its trading for the year ended 31 December on Monday, reporting that as a result of a strong trading performance in the final quarter, underpinned by an increase in the number of clients and an accelerated growth in product sales, its revenue and adjusted EBITDA for the year were expected to be around £13.4m and above £2.1m, respectively.
Read moreDiaceutics begins listed company life on AIM
21st Mar 2019 09:55
(Sharecast News) - Data analytics and implementation services company Diaceutics confirmed the admission of its entire issued ordinary share capital, which comprises 69,583,077 ordinary shares, to trading on AIM on Thursday morning.
Read more